Do imaging techniques and novel biomarkers predict cardiovascular risk and atherosclerosis development in patients with chronic kidney disease?
The NEFRONA project aims to evaluate the utility of imaging and biomarkers for predicting cardiovascular risk and atherosclerosis in CKD patients.
The NEFRONA study will allow us to examine the usefulness of imaging techniques and biomarkers to assess atherosclerosis development and their predictive value in a Spanish population with CKD.
Junyent et al. (Fri,) studied this question.